feed,title,long_url,short_url
MedRxiv,"REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT",https://medrxiv.org/cgi/content/short/2021.10.25.21265462v1?rss=1,https://j.mp/3mgHJQz
